Esketamine: a new frontier in treatment-resistant depression

By Dr Mathew Samuel, Psychiatrist Nedlands

Depression, specifically major depressive disorder (MDD), is a widespread mental health condition that affects hundreds of millions globally.

In Australia, over 1.3 million individuals – 5.9% of the population – are affected.

MDD is characterised by a persistent low mood and loss of interest or pleasure in most activities, accompanied by a range of somatic and cognitive symptoms....

This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.

Existing Users Log In